G. Barbezat and M. Grossman, Intestinal Secretion: Stimulation by Peptides, Science, vol.174, issue.4007, pp.422-426, 1971.
DOI : 10.1126/science.174.4007.422

G. Makhlouf and K. Murthy, Signal Transduction in Gastrointestinal Smooth Muscle, Cellular Signalling, vol.9, issue.3-4, pp.269-76, 1997.
DOI : 10.1016/S0898-6568(96)00180-5

M. Miampamba, P. Germano, S. Arli, H. Wong, and D. Scott, Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons, Regulatory Peptides, vol.105, issue.3, pp.145-154, 2002.
DOI : 10.1016/S0167-0115(02)00003-4

V. Lelievre, G. Favrais, C. Abad, H. Adle-biassette, and Y. Lu, Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: A model for the study of intestinal ileus and Hirschsprung's disease, Peptides, vol.28, issue.9, pp.1688-1689, 2007.
DOI : 10.1016/j.peptides.2007.05.006

F. Paladini, E. Cocco, I. Cascino, F. Belfiore, and D. Badiali, Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene, Neurogastroenterology & Motility, vol.10, issue.1 Pt 1, pp.597-602, 2009.
DOI : 10.1111/j.1365-2982.2009.01284.x

R. Gomariz, A. Arranz, Y. Juarranz, I. Gutierrez-cañ-as, and M. Garcia-gomez, Regulation of TLR expression, a new perspective for the role of VIP in immunity, Peptides, vol.28, issue.9, pp.1825-1832, 2007.
DOI : 10.1016/j.peptides.2007.07.005

E. Gonzales-rey, A. Chorny, and M. Delgado, Regulation of immune tolerance by anti-inflammatory neuropeptides, Nature Reviews Immunology, vol.1070, issue.1, pp.52-63, 2007.
DOI : 10.1038/nri1984

J. Leceta, R. Gomariz, C. Martinez, M. Carrión, and A. Arranz, Vasoactive Intestinal Peptide Regulates Th17 Function in Autoimmune Inflammation, Neuroimmunomodulation, vol.14, issue.3-4, pp.134-138, 2007.
DOI : 10.1159/000110636

B. Lodde, F. Mineshiba, J. Wang, A. Cotrim, and S. Afione, Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome, Annals of the Rheumatic Diseases, vol.65, issue.2, pp.195-200, 2006.
DOI : 10.1136/ard.2005.038232

E. Gonzales-rey, A. Fernandez-martin, A. Chorny, and M. Delgado, Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis, Arthritis & Rheumatism, vol.201, issue.3, pp.864-876, 2006.
DOI : 10.1002/art.21652

M. Laburthe and A. Couvineau, Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP, Regulatory Peptides, vol.108, issue.2-3, pp.165-73, 2002.
DOI : 10.1016/S0167-0115(02)00099-X

S. Sreedharan, J. Huang, M. Cheung, and E. Goetzl, Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene., Proceedings of the National Academy of Sciences, vol.92, issue.7, pp.2939-2982, 1995.
DOI : 10.1073/pnas.92.7.2939

M. Lara-marquez, O. Dorisio, M. , O. Dorisio, T. Shah et al., Selective Gene Expression and Activation-Dependent Regulation of Vasoactive Intestinal Peptide Receptor Type 1 and Type 2 in Human T Cells, The Journal of Immunology, vol.166, issue.4, pp.2522-2530, 2001.
DOI : 10.4049/jimmunol.166.4.2522

F. Toumi, M. Neunlist, M. Denis, T. Oreshkova, and C. Laboisse, Vasoactive intestinal peptide induces IL-8 production in human colonic epithelial cells via MAP kinase-dependent and PKA-independent pathways, Biochemical and Biophysical Research Communications, vol.317, issue.1, pp.187-91, 2004.
DOI : 10.1016/j.bbrc.2004.03.033

M. Kojima, T. Ito, T. Oono, T. Hisano, and H. Igarashi, VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production, Pancreas, vol.30, pp.62-70, 2005.

E. Gonzalez-rey, A. Chorny, A. Fernandez-martin, D. Ganea, and M. Delgado, Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells, Blood, vol.107, issue.9, pp.3632-3640, 2006.
DOI : 10.1182/blood-2005-11-4497

D. Pozo, P. Anderson, and E. Gonzalez-rey, Induction of Alloantigen-Specific Human T Regulatory Cells by Vasoactive Intestinal Peptide, The Journal of Immunology, vol.183, issue.7, pp.4346-59, 2009.
DOI : 10.4049/jimmunol.0900400

M. Delgado, G. Robledo, B. Rueda, N. Varela, O. Valle et al., Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells, Arthritis & Rheumatism, vol.71, issue.4, pp.1010-1019, 2008.
DOI : 10.1002/art.23482

F. Paladini, E. Cocco, A. Cauli, I. Cascino, and A. Vacca, A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B???*2705 in Sardinia, Genes and Immunity, vol.113, issue.8, pp.659-67, 2008.
DOI : 10.1016/j.jneuroim.2007.01.020

C. Chu and T. Rana, Small RNAs: Regulators and guardians of the genome, Journal of Cellular Physiology, vol.17, issue.2, pp.412-421, 2007.
DOI : 10.1002/jcp.21230

S. Hammonds, Dicing and slicing, FEBS Letters, vol.9, issue.26, pp.5822-5831, 2005.
DOI : 10.1016/j.febslet.2005.08.079

J. Doench and P. Sharp, Specificity of microRNA target selection in translational repression, Genes & Development, vol.18, issue.5, pp.504-515, 2004.
DOI : 10.1101/gad.1184404

B. Lewis, C. Burge, and D. Bartel, Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets, Cell, vol.120, issue.1, pp.15-20, 2005.
DOI : 10.1016/j.cell.2004.12.035

K. Pauley, S. Cha, and E. Chan, MicroRNA in autoimmunity and autoimmune diseases, Journal of Autoimmunity, vol.32, issue.3-4, pp.189-94, 2009.
DOI : 10.1016/j.jaut.2009.02.012

A. Liston, L. Lu, O. Carroll, D. Tarakhovsky, A. Rudensky et al., Dicer-dependent microRNA pathway safeguards regulatory T cell function, The Journal of Experimental Medicine, vol.205, issue.9, pp.1993-2004, 2008.
DOI : 10.1038/ng1744

R. Rigby and C. Vinuesa, SiLEncing SLE: the power and promise of small noncoding RNAs, Current Opinion in Rheumatology, vol.20, issue.5, pp.526-557, 2008.
DOI : 10.1097/BOR.0b013e328304b45e

E. Tili, J. Michaille, S. Costinean, and C. Croce, MicroRNAs, the immune system and rheumatic disease, Nature Clinical Practice Rheumatology, vol.8, issue.10, pp.534-575, 2008.
DOI : 10.1038/ncprheum0885

J. Stanczyk, D. Pedrioli, F. Brentano, O. Sanchez-pernaute, and C. Kolling, Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis & Rheumatism, vol.179, issue.Suppl, pp.1001-1010, 2008.
DOI : 10.1002/art.23386

G. Curtale, F. Citarella, C. Carissimi, M. Goldoni, and N. Carucci, An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes, Blood, vol.115, issue.2, pp.265-273, 2010.
DOI : 10.1182/blood-2009-06-225987

T. Van-der-bruggen, S. Nijenhuis, E. Van-raaij, J. Verhoef, and B. Van-asbeck, Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway, Infect Immun, vol.67, pp.3824-3829, 1999.

M. Guha, O. Connel, M. Pawlinski, R. Hollis, A. Mcgovern et al., Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression, Blood, vol.98, issue.5, pp.1429-1439, 2001.
DOI : 10.1182/blood.V98.5.1429

N. Mackman, Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers, J Biol Chem, vol.269, pp.26363-26370, 1994.

B. Bennet, D. Sasaki, B. Murray, O. Leary, E. Sakata et al., SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase, Proceedings of the National Academy of Sciences, vol.98, issue.24, pp.13681-13686, 2001.
DOI : 10.1073/pnas.251194298

V. Fulci, S. Chiaretti, M. Goldoni, G. Azzalin, and N. Carucci, Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia, Blood, vol.109, issue.11, pp.4944-4951, 2007.
DOI : 10.1182/blood-2006-12-062398

A. Martin, L. Zhou, and S. Miller, MicroRNA-managing the TH-17 inflammatory response, Nature Immunology, vol.181, issue.12, pp.1229-1231, 2009.
DOI : 10.1038/nm1715

M. Nahid, K. Pauley, M. Satoh, and E. Chan, miR-146a Is Critical for Endotoxin-induced Tolerance: IMPLICATION IN INNATE IMMUNITY, Journal of Biological Chemistry, vol.284, issue.50, pp.34590-99, 2009.
DOI : 10.1074/jbc.M109.056317

H. Stahl, T. Fauti, N. Ullrich, T. Bopp, and J. Kubach, miR-155 Inhibition Sensitizes CD4+ Th Cells for TREG Mediated Suppression, PLoS ONE, vol.102, issue.9, p.7158, 2009.
DOI : 10.1371/journal.pone.0007158.s006

L. Lim, N. Lau, P. Garrett-engele, A. Grimson, and J. Schelter, Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs, Nature, vol.22, issue.7027, pp.769-773, 2005.
DOI : 10.1016/S0092-8674(00)00015-5

K. Farh, A. Grimson, C. Jan, B. Lewis, and W. Johnston, The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution, Science, vol.310, issue.5755, pp.1817-1821, 2005.
DOI : 10.1126/science.1121158

M. Saunders, H. Liang, and W. Li, Human polymorphism at microRNAs and microRNA target sites, Proceedings of the National Academy of Sciences, vol.104, issue.9, pp.3300-3305, 2007.
DOI : 10.1073/pnas.0611347104

P. Sethupathy and F. Collins, MicroRNA target site polymorphisms and human disease, Trends in Genetics, vol.24, issue.10, pp.489-497, 2008.
DOI : 10.1016/j.tig.2008.07.004

K. Takeda and S. Akira, TLR signaling pathways, Seminars in Immunology, vol.16, issue.1, pp.3-9, 2004.
DOI : 10.1016/j.smim.2003.10.003